Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmette-Guérin Treatment Failure
1. Department of Urology, Herbert Irving Cancer Center, Columbia University Medical Center, New York, New York;2. Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, New York